Global NGS Diagnostics for Rare Diseases Market: Transforming Precision Medicine Through Genomic Innovation
The global market for Next-Generation Sequencing (NGS) diagnostics in rare diseases is entering a phase of rapid expansion, driven by breakthroughs in genomic science, declining sequencing costs, and growing demand for early and precise diagnosis. Valued at USD 889 million … Read more